Evaluating the effects of Borageseed’s oiloninflammatory in treatment of acute respiratory distress syndrome (ARDS) patients
Phase 3
- Conditions
- Acute Respiratory Distress Syndrome (ARDS).Severe acute respiratory syndrome [SARS], unspecified
- Registration Number
- IRCT2016072420592N7
- Lead Sponsor
- Vice chancellor for research, Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclution Criteria:
Patients with acute respiratory distress syndrome.
Exclution Criteria:
Liver diseases; blood coagulation disorders;gastrointestinal bleeding; inflammatory bowel disease; diarrhea and other gastrointestinal malignancies under Routine treatment of inflammatory diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interlukiun 8. Timepoint: In start of the study and 3th and 5th days. Method of measurement: Human Boster Kit.
- Secondary Outcome Measures
Name Time Method Tumor necrosis factor alpha. Timepoint: In start of the study and 3th and 5th days. Method of measurement: Kit.